Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats.
Rat kidney contains two different calpain isozymes distinguishable on the basis of their Ca2+ requirement and of their activation mechanisms. The two calpain isozymes are present in comparable amounts in kidney of normotensive and hypertensive rats of the Milan strain. Conversely, the level of the natural inhibitor of calpain is significantly decreased in kidney of hypertensive rats as compared to control normotensive rats. This deficiency is more pronounced in the cortical region than in other kidney fractions. These results taken together with previous observations indicating the existence of an identical defect in red cells from the same hypertensive rat strain, (Pontremoli, S., Melloni, E., Salamino, F., Sparatore, B., Viotti, P., Michetti, M., Duzzi, L., and Bianchi, G. (1986) Biochem. Biophys. Res. Commun. 138, 1370-1375) emphasize the possible role of an unbalanced intracellular proteolytic system in the development of genetically determined hypertension.
D000818:Animals; D002154:Calpain / Q000037:antagonists & inhibitors*; D006023:Glycoproteins / Q000378:metabolism*; D006973:Hypertension / Q000201:enzymology*; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D007668:Kidney / Q000201:enzymology*; D007672:Kidney Cortex / Q000201:enzymology; D007679:Kidney Medulla / Q000201:enzymology; D008297:Male; D011480:Protease Inhibitors / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains
D006023:Glycoproteins; D007527:Isoenzymes; D011480:Protease Inhibitors; C039304:calpain inhibitors; D002154:Calpain